GB9103302D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB9103302D0
GB9103302D0 GB919103302A GB9103302A GB9103302D0 GB 9103302 D0 GB9103302 D0 GB 9103302D0 GB 919103302 A GB919103302 A GB 919103302A GB 9103302 A GB9103302 A GB 9103302A GB 9103302 D0 GB9103302 D0 GB 9103302D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919103302A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919103302A priority Critical patent/GB9103302D0/en
Publication of GB9103302D0 publication Critical patent/GB9103302D0/en
Priority to AU12272/92A priority patent/AU1227292A/en
Priority to PCT/GB1992/000257 priority patent/WO1992014466A1/en
Priority to ZA921093A priority patent/ZA921093B/en
Priority to IE048492A priority patent/IE920484A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
GB919103302A 1991-02-16 1991-02-16 Pharmaceutical formulations Pending GB9103302D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB919103302A GB9103302D0 (en) 1991-02-16 1991-02-16 Pharmaceutical formulations
AU12272/92A AU1227292A (en) 1991-02-16 1992-02-13 Pharmaceutical antitussive compositions
PCT/GB1992/000257 WO1992014466A1 (en) 1991-02-16 1992-02-13 Pharmaceutical antitussive compositions
ZA921093A ZA921093B (en) 1991-02-16 1992-02-14 Pharmaceutical formulations
IE048492A IE920484A1 (en) 1991-02-16 1992-02-14 Pharmaceutical Formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103302A GB9103302D0 (en) 1991-02-16 1991-02-16 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB9103302D0 true GB9103302D0 (en) 1991-04-03

Family

ID=10690127

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919103302A Pending GB9103302D0 (en) 1991-02-16 1991-02-16 Pharmaceutical formulations

Country Status (5)

Country Link
AU (1) AU1227292A (en)
GB (1) GB9103302D0 (en)
IE (1) IE920484A1 (en)
WO (1) WO1992014466A1 (en)
ZA (1) ZA921093B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
ES2138074T3 (en) * 1993-03-29 2000-01-01 Lynchris Pharm Ltd ANESTHETIC AEROSOL BASED ON LIDOCAINE.
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
SE9601528D0 (en) 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as an antitissue agent
CA2334481A1 (en) * 1998-06-09 1999-12-16 Nortran Pharmaceuticals Inc. Compositions and methods for treatment of cough
ATE251447T1 (en) * 1998-12-11 2003-10-15 Pharmachemie Bv PHARMACEUTICAL PREPARATIONS FOR INHALING AN OPIOID
WO2002000218A2 (en) 2000-06-23 2002-01-03 Mayo Foundation For Medical Education And Research Methods of treating neutrophil-related diseases with topical anesthetics
EP2987788A1 (en) * 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
JP4865330B2 (en) 2002-12-13 2012-02-01 デュレクト コーポレーション Oral drug delivery system
CA2707969C (en) 2007-12-06 2017-04-18 Pain Therapeutics, Inc. Micronized opioid compositions, formulations and dosage forms and methods of making same
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
TW201521769A (en) 2013-03-15 2015-06-16 Durect Corp Compositions with a rheological modifier to reduce dissolution variability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
US4241048A (en) * 1979-05-01 1980-12-23 Bristol-Myers Company Suspension composition of benzocaine
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
IT1187743B (en) * 1985-09-26 1987-12-23 Prodotti Formenti Srl DESTRORPHANE BASED PHARMACEUTICAL COMPOSITIONS FOR INSTRANASAL APPLICATION
FR2601246B1 (en) * 1986-07-11 1990-01-05 Bouchara Sa NOVEL DEXTROMETHORPHANE-BASED ANTI-TUSSIVE COMPOSITIONS AND THEIR PROCESS FOR OBTAINING SAME.

Also Published As

Publication number Publication date
IE920484A1 (en) 1992-08-26
ZA921093B (en) 1993-01-27
AU1227292A (en) 1992-09-15
WO1992014466A1 (en) 1992-09-03

Similar Documents

Publication Publication Date Title
SG55163A1 (en) Pharmaceutical formulations
ZA921877B (en) Pharmaceutical aerosol formulations
IL102777A0 (en) Pharmaceutical combination formulation
GB9114950D0 (en) Pharmaceutical formulation
ZA921093B (en) Pharmaceutical formulations
AP9000236A0 (en) Pharmaceutical formulations
GB9201639D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
GB9311030D0 (en) Pharmaceutical formulations
GB9216061D0 (en) Pharmaceutical combination formulation
GB9124803D0 (en) Pharmaceutical formulations
GB9103444D0 (en) Pharmaceutical formulations
GB9114621D0 (en) Pharmaceutical formulations
ZA92618B (en) Pharmaceutical formulations
GB9125005D0 (en) Pharmaceutical formulations
GB9111858D0 (en) Pharmaceutical formulations
GB9014391D0 (en) Pharmaceutical formulations
GB9221244D0 (en) Pharmaceutical formulations
GB9207338D0 (en) Pharmaceutical formulations
GB9203212D0 (en) Pharmaceutical formulations
GB9204774D0 (en) Pharmaceutical formulations
GB9307003D0 (en) Pharmaceutical formulations
GB9217602D0 (en) Pharmaceutical formulations
GB9116467D0 (en) Pharmaceutical formulation
GB9122115D0 (en) Pharmaceutical formulation